8-74004819-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015364.5(LY96):āc.136A>Gā(p.Ile46Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000165 in 1,578,518 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015364.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LY96 | NM_015364.5 | c.136A>G | p.Ile46Val | missense_variant | 2/5 | ENST00000284818.7 | NP_056179.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LY96 | ENST00000284818.7 | c.136A>G | p.Ile46Val | missense_variant | 2/5 | 1 | NM_015364.5 | ENSP00000284818.2 | ||
LY96 | ENST00000518893.1 | c.113-5182A>G | intron_variant | 3 | ENSP00000430533.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250382Hom.: 1 AF XY: 0.0000148 AC XY: 2AN XY: 135404
GnomAD4 exome AF: 0.0000168 AC: 24AN: 1426324Hom.: 1 Cov.: 28 AF XY: 0.0000141 AC XY: 10AN XY: 710142
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.136A>G (p.I46V) alteration is located in exon 2 (coding exon 2) of the LY96 gene. This alteration results from a A to G substitution at nucleotide position 136, causing the isoleucine (I) at amino acid position 46 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at